| __timestamp | BioCryst Pharmaceuticals, Inc. | Pharming Group N.V. |
|---|---|---|
| Wednesday, January 1, 2014 | 51796000 | 14182353 |
| Thursday, January 1, 2015 | 72758000 | 15503028 |
| Friday, January 1, 2016 | 61008000 | 16183585 |
| Sunday, January 1, 2017 | 66962000 | 22382849 |
| Monday, January 1, 2018 | 84888000 | 33038206 |
| Tuesday, January 1, 2019 | 107068000 | 31777040 |
| Wednesday, January 1, 2020 | 122964000 | 41464134 |
| Friday, January 1, 2021 | 208808000 | 67178053 |
| Saturday, January 1, 2022 | 253297000 | 52531000 |
| Sunday, January 1, 2023 | 216566000 | 68914000 |
Unleashing the power of data
In the ever-evolving world of biotechnology, research and development (R&D) spending is a critical indicator of a company's commitment to innovation. Over the past decade, BioCryst Pharmaceuticals, Inc. and Pharming Group N.V. have demonstrated contrasting strategies in their R&D investments.
BioCryst has shown a remarkable upward trend in R&D expenses, with a staggering 400% increase from 2014 to 2023. This surge underscores their aggressive pursuit of groundbreaking therapies, particularly in the field of rare diseases.
In contrast, Pharming Group's R&D spending has grown by approximately 385% over the same period. While their investment is more conservative compared to BioCryst, it reflects a steady commitment to enhancing their product pipeline.
These trends highlight the dynamic nature of the biotech industry, where strategic R&D investments can pave the way for future breakthroughs.
Comparing Innovation Spending: Johnson & Johnson and Pharming Group N.V.
Who Prioritizes Innovation? R&D Spending Compared for Incyte Corporation and BioCryst Pharmaceuticals, Inc.
Who Prioritizes Innovation? R&D Spending Compared for Sarepta Therapeutics, Inc. and BioCryst Pharmaceuticals, Inc.
Research and Development Investment: Ascendis Pharma A/S vs BioCryst Pharmaceuticals, Inc.
Pharming Group N.V. or Grifols, S.A.: Who Invests More in Innovation?
R&D Insights: How Pharming Group N.V. and Corcept Therapeutics Incorporated Allocate Funds
R&D Insights: How Pharming Group N.V. and MannKind Corporation Allocate Funds
Comparing Innovation Spending: Pharming Group N.V. and Novavax, Inc.
Research and Development Expenses Breakdown: Rhythm Pharmaceuticals, Inc. vs BioCryst Pharmaceuticals, Inc.
Research and Development: Comparing Key Metrics for PTC Therapeutics, Inc. and BioCryst Pharmaceuticals, Inc.
Protagonist Therapeutics, Inc. vs BioCryst Pharmaceuticals, Inc.: Strategic Focus on R&D Spending
Analyzing R&D Budgets: MannKind Corporation vs BioCryst Pharmaceuticals, Inc.